The present invention relates to dihydrofolate reductase inhibitors having an aromatic group and a heteroaromatic group linked by a methylene group; and methods of treatment and pharmaceutical compositions that utilize or comprise one or more of such dihydrofolate reductase inhibitors.

 
Web www.patentalert.com

< Boronic ester and acid compounds, synthesis and uses

< Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient

> Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline

> RelA-associated inhibitor, process for producing the same and utilization thereof
~ 00294